2 papers and 0 clinical trials exploring ayahuasca as a treatment for microdosing.
Ayahuasca is a botanical decoction combining DMT with MAO-inhibiting harmala alkaloids, producing intense psychedelic effects lasting 3-6 hours. Clinical trials show rapid, large antidepressant effects from a single dose, with a favourable safety profile in controlled settings.
Full Ayahuasca profileMicrodosing involves the regular consumption of sub-hallucinogenic doses of psychedelics, primarily for cognitive enhancement and emotional wellbeing. Although popularised through anecdotal reports, rigorous scientific evidence on its effects is still limited, pointing to a critical need for further research in this emerging field.
Full Microdosing profileNo clinical trials have been tagged with both Ayahuasca and Microdosing yet.
Trials are continuously being added as new studies are registered.